Solid tumors
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients diagnosed with malignant solid tumor pathologically from January 1, 2015 (2) Patients with high-grade tumors requiring perioperative chemotherapy or with unresectable or recurrent lesions (3) Patients who fully understand this research plan and can give their consent (4) Patients aged 20 years or older at the time of informed consent
Exclusion criteria
Exclusion criteria: Patients judged by researchers to be uneligible as research subjects
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Frequency of detection of actionable genetic alternations | — |
Countries
Japan
Contacts
Graduate School of Medical Sciences, Kyushu University Department of Surgery and Oncology